000 | 01766 a2200577 4500 | ||
---|---|---|---|
005 | 20250516195237.0 | ||
264 | 0 | _c20151112 | |
008 | 201511s 0 0 eng d | ||
022 | _a2041-1723 | ||
024 | 7 |
_a10.1038/ncomms4296 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTanaka, Eriko | |
245 | 0 | 0 |
_aNotch2 activation ameliorates nephrosis. _h[electronic resource] |
260 |
_bNature communications _c2014 |
||
300 |
_a3296 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aCHO Cells |
650 | 0 | 4 | _aCricetinae |
650 | 0 | 4 | _aCricetulus |
650 | 0 | 4 | _aDoxorubicin |
650 | 0 | 4 | _aDrug Evaluation, Preclinical |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKidney Diseases _xchemically induced |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 | _aMice, Inbred ICR |
650 | 0 | 4 | _aMice, Nude |
650 | 0 | 4 |
_aPodocytes _xdrug effects |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
650 | 0 | 4 |
_aReceptor, Notch2 _xagonists |
700 | 1 | _aAsanuma, Katsuhiko | |
700 | 1 | _aKim, Eunhee | |
700 | 1 | _aSasaki, Yu | |
700 | 1 | _aOliva Trejo, Juan Alejandro | |
700 | 1 | _aSeki, Takuto | |
700 | 1 | _aNonaka, Kanae | |
700 | 1 | _aAsao, Rin | |
700 | 1 | _aNagai-Hosoe, Yoshiko | |
700 | 1 | _aAkiba-Takagi, Miyuki | |
700 | 1 | _aHidaka, Teruo | |
700 | 1 | _aTakagi, Masatoshi | |
700 | 1 | _aKoyanagi, Akemi | |
700 | 1 | _aMizutani, Shuki | |
700 | 1 | _aYagita, Hideo | |
700 | 1 | _aTomino, Yasuhiko | |
773 | 0 |
_tNature communications _gvol. 5 _gp. 3296 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/ncomms4296 _zAvailable from publisher's website |
999 |
_c23544337 _d23544337 |